About
Mindbio Therapeutics Corp. (CN:MBIO) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 24 2026
MindBio Appoints National Drug Policy & Mining Industry Expert to Lead South American Mining Industry Commercialisation
Feb 2 2026
MindBio to Revolutionise Drug and Alcohol Testing in the Mining Industry using AI Voice-Based Drug & Alcohol Detection Solution
Jul 8 2025
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
Jul 7 2025
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
Mar 5 2025
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
Financials
Revenue
-CA$630.65 K
Market Cap
CA$5.99 M
EPS
-3.43
Translate